The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes.
about
Patient perceptions of quality of life with diabetes-related complications and treatmentsHealth economics: the start of clinical freedom.Patient preferences in the treatment of diabetic retinopathy.Preferences of diabetes patients and physicians: a feasibility study to identify the key indicators for appraisal of health care valuesPatient-centered medicine and patient-oriented research: improving health outcomes for individual patientsEffect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.Health utilities for children and adults with type 1 diabetesOlder Adults' Perceived Challenges With Health Care Providers Treating Their Type 2 Diabetes and Comorbid Conditions.Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trialBaseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trialPersonalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitusThe effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients.Variation in treatment preferences and care goals among older patients with diabetes and their physiciansUtilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastasesStratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectivenessCost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications.A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.Approaches to treatment of type 2 diabetes.Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.
P2860
Q24644699-098454CD-3D05-458F-8024-72B302114BEBQ33618392-A01F5E56-CDE6-4EDE-A9FD-3E93916256D2Q33928715-5617ECC6-7421-4EA4-BF2E-72BD8DFFEEADQ34338429-F9DE12B3-92D4-4ED0-A7EF-6978687951CDQ34538048-A00AC13E-9280-45F9-8F75-E71D2A183179Q34988073-49DFDA5E-B448-49B2-B4FE-FFE42FC2B8B9Q35533800-EA0E615A-4742-4128-A8D3-94EEDEEDF399Q35906503-C474A34A-2A6E-45C9-A416-8D4BEEDE1F30Q35945237-A18BFCC6-771C-4051-94CF-6DB9D6B4294DQ36091640-737065C2-4EF4-472E-9621-48414CECF828Q36136786-C32C2F14-A984-4E64-9DA6-16C8F1715AECQ36295307-0B0F17A8-63C4-4122-B655-803F26685799Q36691785-F1F612A8-4728-4C7B-AF9E-A0F72E701A63Q36925939-F350C831-8C2E-49A3-8CFF-D030D4A08EE2Q37038320-348BAC86-721D-41D2-9A2E-196AE6CB49F3Q37137827-944F7569-159F-431E-BF0D-303001A473A9Q37163756-D8A7BCCA-9B52-46BB-AEF3-C6C9809D64C2Q37193604-4B306503-B370-440F-B3BD-572AE8C2EF70Q37403160-6B691F92-34DE-4AC9-BB3E-87C207AA0E4FQ37862622-28E21DF0-4F79-46BC-BF30-505CA5A460FDQ38212030-97D17699-55F5-4B30-B3F2-56D77F8821BBQ39743309-9BCD7F8C-FD69-4752-A8EF-EEF8EE452E3CQ42349595-490CF5A5-217F-4A96-A4FA-EEA22AF3A463Q47195337-55AE0779-02B4-49CF-B685-A5C7F931845A
P2860
The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The impact of patient preferen ...... ients with new-onset diabetes.
@ast
The impact of patient preferen ...... ients with new-onset diabetes.
@en
type
label
The impact of patient preferen ...... ients with new-onset diabetes.
@ast
The impact of patient preferen ...... ients with new-onset diabetes.
@en
prefLabel
The impact of patient preferen ...... ients with new-onset diabetes.
@ast
The impact of patient preferen ...... ients with new-onset diabetes.
@en
P2093
P2860
P1433
P1476
The impact of patient preferen ...... ients with new-onset diabetes.
@en
P2093
David O Meltzer
Elbert S Huang
Marshall H Chin
Morgan Shook
P2860
P304
P356
10.2337/DIACARE.29.02.06.DC05-1443
P407
P577
2006-02-01T00:00:00Z